CV Sciences, Inc. (CVSI)
| Market Cap | 5.23M |
| Revenue (ttm) | 14.37M |
| Net Income (ttm) | -1.48M |
| Shares Out | 184.26M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,500 |
| Average Volume | 139,498 |
| Open | 0.0300 |
| Previous Close | 0.0300 |
| Day's Range | 0.0300 - 0.0300 |
| 52-Week Range | 0.0230 - 0.0500 |
| Beta | 0.35 |
| RSI | 35.20 |
| Earnings Date | Nov 13, 2025 |
About CV Sciences
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements, hemp-based cannabidiol (CBD), and plant based food products in North America. It offers its products under the PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in Jan... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
CV Sciences Inc (CVSI) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
CV Sciences Inc (CVSI) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovation
Q3 2025 CV Sciences Inc Earnings Call Transcript
Q3 2025 CV Sciences Inc Earnings Call Transcript
CV Sciences outlines new non-cannabinoid product launches in 2026 while adapting to regulatory changes
CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsBrendan HawkinsJoseph Dowling - CEO, Secretary &...
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...
CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & ...
CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus | CVSI Stock News
CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus
Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond. SAN DIEGO, CALIFORNIA / ACCE...
CV Sciences, Inc. (CVSI) Q2 2025 Earnings Call Transcript
CV Sciences Non-GAAP EPS of $0.00, revenue of $3.62M
CV Sciences Sales Down 10 Percent
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extr...
CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 8, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in he...
Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 24, 2025
GAINERS: Trees (OTC: CANN) shares closed up 124.58% at $0.02 4Front Ventures (OTC: FFNTF) shares closed up 100.00% at $0.0002 GrowLife (OTC: PHOT) shares closed up 100.00% at $0.0004 Belgravia Hart...
CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3
SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hem...
Cannabis Stock Gainers And Losers From June 13, 2025
GAINERS: Mexco Energy (AMEX: MXC) shares closed up 40.45% at $11.91 CordovaCann (OTC: LVRLF) shares closed up 33.78% at $0.06 iAnthus Capital Hldgs (OTC: ITHUF) shares closed up 12.50% at $0.00 CNB...
Cannabis Stock Gainers And Losers From May 29, 2025
GAINERS: Rocky Mountain High (OTC: RMHB) shares closed up 36.00% at $0.00 CV Sciences (OTC: CVSI) shares closed up 16.87% at $0.03 MariMed (OTC: MRMD) shares closed up 13.70% at $0.09 Currenc Group...
Cannabis Stock Movers For May 20, 2025
GAINERS: 1933 Industries (OTC: TGIFF) shares closed up 19.61% at $0.01 CLS Holdings USA (OTC: CLSH) shares closed up 14.16% at $0.03 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 12.50% at $0.0...
Marijuana Stock Movers For May 15, 2025
GAINERS: Nextleaf Solutions (OTC: OILFF) shares closed up 13.87% at $0.04 FLUENT (OTC: CNTMF) shares closed up 12.00% at $0.06 Urban-gro (NASDAQ: UGRO) shares closed up 8.67% at $0.38 CNBX Pharmace...
CV Sciences Non-GAAP EPS of $0.00, revenue of $3.6M
CV Sciences, Inc. (CVSI) Q1 2025 Earnings Call Transcript
CV Sciences, Inc. Reports First Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extract...
CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025
SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
Marijuana Stock Movers For May 8, 2025
GAINERS: CNBX Pharmaceuticals (OTC: CNBX) shares closed up 15.00% at $0.00 Cronos Group (NASDAQ: CRON) shares closed up 9.19% at $2.00 SOL Global Investments (OTC: SOLCF) shares closed up 9.15% at ...